BPC-157 TB-500 Peptide: What the Stack Is and How It Works

BPC-157 TB-500 peptide stacks are widely discussed online. Learn how these peptides work, common blends, safety concerns, and US legal status.

ARTICLE OVERVIEW

BPC-157 TB-500 peptide stacks are widely discussed online. Learn how these peptides work, common blends, safety concerns, and US legal status.

BPC-157 and TB-500 are synthetic peptides sold as research chemicals, and the BPC-157 TB-500 peptide stack — commonly nicknamed the "Wolverine stack" — is a combination studied in animal models for tissue repair. BPC-157 is a 15-amino-acid fragment derived from a protein found in human gastric juice, while TB-500 is a synthetic analog of thymosin beta-4. Neither peptide is FDA-approved for human use in the United States, so any human use is off-label, unregulated, and not supported by controlled clinical trials.

What Is BPC-157?

BPC-157 (often called "body protection compound") is a pentadecapeptide, meaning it is built from 15 amino acids. Researchers isolated it from a fragment of human gastric juice protein, and laboratory work on it dates back to the early 1990s.

In rodent studies, BPC-157 has been examined for effects on tendon, ligament, muscle, gut lining, and blood vessel tissue. Nearly all of that evidence comes from animal models rather than randomized human trials.

BPC-157 is not FDA-approved for human use in the United States.

What Is TB-500?

TB-500 is a synthetic version of thymosin beta-4, a protein that occurs naturally in many human cells. The fragment most often researched is the active N-terminal portion of that molecule.

Animal research on thymosin beta-4 and TB-500 centers on cell migration, actin regulation, and tissue remodeling — the processes involved in wound healing and connective-tissue flexibility. Controlled human data on TB-500 specifically is very limited.

TB-500 is not approved by the FDA for human use and is sold only as a research chemical.

Why People Stack BPC-157 and TB-500 Together

The appeal of the bpc 157 and tb 500 combo is a division of labor. BPC-157 is usually described in the literature as acting on local tissue and the gut, while TB-500 research focuses on cell migration and connective-tissue remodeling.

Because the two compounds appear to work through different signaling pathways, users theorize that combining them may be more useful than either one alone. That theory has not been proven in humans.

  • Different mechanisms: tissue-protective signaling versus cell-migration signaling.
  • Convenience: pre-mixed vials reduce the number of injections.
  • Shared targets: tendons, ligaments, and muscle are the most discussed areas.

Every claim about peptides bpc 157 and tb-500 in this article carries the same caveat: animal data is not the same as human evidence.

Blend Formats, Vial Sizes, and "Wolverine" Products

Suppliers sell BPC-157 and TB-500 separately or as a pre-mixed blend. The most common configuration is a bpc 157 tb 500 10mg vial, which typically holds 5 mg of each peptide in one lyophilized powder.

FormatTypical contentsNotes
Separate vials5 mg or 10 mg BPC-157 plus 5 mg or 10 mg TB-500Allows independent measurement of each peptide
Pre-mixed blend10 mg total (5 mg + 5 mg)Sold as a "BPC-157/TB-500 blend"
Wolverine stack10 mg or 20 mg combinedMarketing name for the same two peptides
Oral capsulesOften 250–500 mcg per capsuleDiscussed as having lower bioavailability than injection

"Wolverine" is marketing shorthand, not a distinct chemical. The tb 500 and bpc 157 blend inside those vials is the same pair of peptides sold in separate containers.

What the Research Suggests — and Where Evidence Is Thin

Most published data on these peptides comes from rodents, and results are generally described as promising rather than conclusive. Randomized controlled human trials are scarce for both compounds.

Tendon, ligament, and joint tissue

Animal studies on BPC-157 report faster healing of injured tendons and ligaments. People searching for bpc 157 tb 500 for arthritis are usually chasing that same connective-tissue angle, but no controlled human trial supports using either peptide to treat arthritis or joint disease.

Muscle and recovery

Discussions about bpc-157 and tb-500 for muscle growth tend to blend injury-recovery research with general athletic goals. There is no human evidence that either peptide builds muscle by itself.

Gut and other tissue

Rodent work has also looked at BPC-157 in models of gut lining injury and inflammation. These findings are preliminary and have not been translated into approved human therapies.

Dosing discussions

There is no FDA-approved dose for either peptide, because there is no approved human product. Online protocols vary widely, and people comparing bpc-157 tb-500 oral vs injection generally note that injected forms are described as more bioavailable — which also increases the risk of contamination, infection, and dosing errors.

Cost

Research-grade pricing depends on vial size, vendor, and purity claims. Shoppers who ask how much does bpc-157 peptide cost will find a wide range, and an unusually low price usually signals unverified purity or an underfilled vial.

Sourcing and legal status

Neither peptide can legally be sold as a dietary supplement or an approved drug in the US. Products labeled "not for human consumption" are research chemicals, and people who look for where to buy bpc-157 and tb-500 are generally browsing vendors that operate in a legal gray zone.

Safety

User reports mention injection-site reactions, nausea, and headache, but there is no large safety database for either peptide. Because these products are unregulated, sterility and actual peptide content are not guaranteed. Anyone considering them should talk with a healthcare professional first. This article is informational only and is not medical advice.

RELATED PEPTIDE TOPICbody protection compound-157

Frequently Asked Questions

What is the BPC-157 and TB-500 peptide stack used for?

People research the stack for connective-tissue repair, tendon and ligament injuries, muscle recovery, and joint discomfort. The supporting evidence comes mainly from rodent studies, not controlled human trials. Neither peptide is FDA-approved for any human use.

Can BPC-157 and TB-500 be mixed together in one vial or syringe?

Vendors sell pre-mixed blends, usually 5 mg of each peptide in a 10 mg vial, and some users combine them in a single syringe. Mixing does not make either peptide stronger, and combining two unregulated powders raises the risk of contamination. A healthcare professional should be involved in any decision about injectable products.

Are BPC-157 and TB-500 legal or FDA-approved in the US?

Neither BPC-157 nor TB-500 is FDA-approved for human use, and neither can legally be sold as a dietary supplement. They are sold as research chemicals labeled "not for human consumption." Buying or possessing them for personal injection is a legal gray area that can vary by state.

Research information notice

This page provides educational research information and does not replace medical advice, diagnosis, or treatment.